Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||
| Net Income | -16,115 | -3,828 | -8,931 |
| Depreciation Amortization | 25 | 12 | 44 |
| Accounts payable and accrued liabilities | 270 | -54 | N/A |
| Other Working Capital | -1,371 | -3,153 | 354 |
| Other Operating Activity | 5,313 | 145 | 79 |
| Operating Cash Flow | $-11,878 | $-6,878 | $-8,454 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -8 | -10 | -76 |
| Investing Cash Flow | $-8 | $-10 | $-76 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | -70 | 0 | 52,312 |
| Financing Cash Flow | $-70 | $N/A | $52,312 |
| Beginning Cash Position | 51,660 | 51,660 | 7,878 |
| End Cash Position | 39,704 | 44,772 | 51,660 |
| Net Cash Flow | $-11,956 | $-6,888 | $43,782 |
| Free Cash Flow | |||
| Operating Cash Flow | -11,878 | -6,878 | -8,454 |
| Capital Expenditure | -8 | -10 | N/A |
| Free Cash Flow | -11,886 | -6,888 | -8,454 |